FDA official logo
GSRS logo
PFDA official logo

CLEVIDIPINE

  • UNII: 19O2GP3B7Q
  • Formula: C21H23Cl2NO6
  • Preferred Substance Name: CLEVIDIPINE
  • InChIKey: KPBZROQVTHLCDU-UHFFFAOYSA-N

  • 167221-71-8
  • (BUTANOYLOXY)METHYL METHYL (4RS)-4-(2,3-DICHLOROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE
  • 3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-((1-OXOBUTOXY)METHYL) ESTER
  • 3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, METHYL (1-OXOBUTOXY)METHYL ESTER
  • CLEVIDEPINE
  • CLEVIDEPINE [VANDF]
  • CLEVIDEPINE BUTYRATE
  • CLEVIDEPINE BUTYRATE [VANDF]
  • CLEVIDIPINE [INN]
  • CLEVIDIPINE [MART.]
  • CLEVIDIPINE [MI]
  • CLEVIDIPINE [ORANGE BOOK]
  • CLEVIDIPINE [USAN]
  • CLEVIDIPINE [VANDF]
  • CLEVIDIPINE [WHO-DD]
  • CLEVIDIPINE BUTYRATE
  • CLEVIDIPINE BUTYRATE [ORANGE BOOK]
  • CLEVIDIPINE BUTYRATE [VANDF]
  • CLEVIPREX
  • H324/38
  • H-324/38

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.